HLS Therapeutics (OTCMKTS:HLTRF – Get Free Report) and Jupiter Wellness (NASDAQ:JUPW – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation and institutional ownership.
Earnings and Valuation
This table compares HLS Therapeutics and Jupiter Wellness”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
HLS Therapeutics | N/A | N/A | N/A | N/A | N/A |
Jupiter Wellness | $5.96 million | 4.33 | -$15.22 million | ($0.55) | -1.71 |
HLS Therapeutics has higher earnings, but lower revenue than Jupiter Wellness.
Institutional & Insider Ownership
Analyst Recommendations
This is a summary of recent ratings and price targets for HLS Therapeutics and Jupiter Wellness, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
HLS Therapeutics | 0 | 1 | 0 | 0 | 2.00 |
Jupiter Wellness | 0 | 0 | 0 | 0 | 0.00 |
HLS Therapeutics presently has a consensus price target of $5.00, indicating a potential upside of 83.15%. Given HLS Therapeutics’ stronger consensus rating and higher possible upside, research analysts clearly believe HLS Therapeutics is more favorable than Jupiter Wellness.
Profitability
This table compares HLS Therapeutics and Jupiter Wellness’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
HLS Therapeutics | N/A | N/A | N/A |
Jupiter Wellness | -210.13% | -211.48% | -117.20% |
Summary
HLS Therapeutics beats Jupiter Wellness on 5 of the 8 factors compared between the two stocks.
About HLS Therapeutics
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.
About Jupiter Wellness
Jupiter Wellness, Inc., a wellness company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
Receive News & Ratings for HLS Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HLS Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.